Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 21;109(1):e119-e129.
doi: 10.1210/clinem/dgad490.

Nonalcoholic Fatty Liver Disease, Liver Fibrosis, and Utility of Noninvasive Scores in Patients With Acromegaly

İmdat Eroğlu  1 , Burcin Gonul Iremli  1   2 , Ilkay S Idilman  3 , Deniz Yuce  4 , Incilay Lay  5 , Deniz Akata  3 , Tomris Erbas  1   2
Affiliations

Nonalcoholic Fatty Liver Disease, Liver Fibrosis, and Utility of Noninvasive Scores in Patients With Acromegaly

İmdat Eroğlu et al. J Clin Endocrinol Metab. .

Abstract

Context: Nonalcoholic fatty liver disease (NAFLD) is a metabolical disorder and can lead to liver fibrosis. Because it is commonly seen, several noninvasive scores (NS) have been validated to identify high-risk patients. Patients with NAFLD have been shown to have higher serum angiopoietin-like protein-8 (ANGPTL-8) levels.

Objective: The risk of NAFLD is known insufficiently in acromegaly. Moreover, the utility of the NS and the link between NAFLD and ANGPTL-8 in acromegaly is unknown.

Methods: Thirty-two patients with acromegaly (n = 15, active [AA] and n = 17, controlled acromegaly [CA]) and 19 healthy controls were included. Magnetic resonance imaging (MRI)-proton density fat fraction (PDFF) was used to evaluate hepatic steatosis, and magnetic resonance elastography to evaluate liver stiffness measurement. ANGPTL-8 levels were measured with ELISA.

Results: Median liver MRI-PDFF and NAFLD prevalence in AA were lower than in CA (P = .026 and P < .001, respectively). Median magnetic resonance elastography-liver stiffness measurement were similar across groups. Of the NS, visceral adiposity index, fatty liver index, hepatic steatosis index, and triglyceride-glucose index (TyG) all showed positive correlation with the liver MRI-PDFF in the control group. However, only TyG significantly correlated with liver fat in the AA and CA groups. There was no correlation between traditional NAFLD risk factors (body mass index, waist circumference, C-reactive protein, homeostasis model assessment for insulin resistance, visceral adipose tissue) and liver MRI-PDFF in the AA and CA. Patients with acromegaly with NAFLD had lower GH, IGF-1, and ANGPTL-8 levels than in those without NAFLD (P = .025, P = .011, and P = .036, respectively).

Conclusion: Active acromegaly may protect from NAFLD because of high GH. In patients with acromegaly, NAFLD risk cannot be explained with classical risk factors; hence, additional risk factors must be identified. TyG is the best score to evaluate NAFLD risk. Lower ANGPTL-8 in patients with acromegaly and NAFLD implies this hormone may be raised because of insulin resistance rather than being a cause for NAFLD.

Keywords: ANGPTL-8; MRE-LSM; MRI-PDFF; NAFLD; acromegaly; growth hormone; noninasive scores.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) Distribution of GH in those with and without NAFLD (B) Distribution of IGF-1 in those with and without NAFLD (C) Distribution of serum angiopoietin-like protein-8 in those with and without NAFLD ANGPTL-8, angiopoietin-like protein-8; NAFLD, nonalcoholic fatty liver disease; NAFLD-, absence of NAFLD; NAFLD+, presence of NAFLD.
See this image and copyright information in PMC

References

    1. Ruissen MM, Mak AL, Beuers U, Tushuizen ME, Holleboom AG. Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease. Eur J Endocrinol. 2020;183(3):R57‐R73. - PubMed
    1. Marino L, Jornayvaz FR. Endocrine causes of nonalcoholic fatty liver disease. World J Gastroenterol. 2015;21(39):11053‐11076. - PMC - PubMed
    1. Fellinger P, Wolf P, Pfleger L, et al. . Increased ATP synthesis might counteract hepatic lipid accumulation in acromegaly. JCI Insight. 2020;5(5):e134638. - PMC - PubMed
    1. Winhofer Y, Wolf P, Krššák M, et al. . No evidence of ectopic lipid accumulation in the pathophysiology of the acromegalic cardiomyopathy. J Clin Endocrinol Metab. 2014;99(11):4299‐4306. - PubMed
    1. Bredella MA, Schorr M, Dichtel LE, et al. . Body composition and ectopic lipid changes with biochemical control of acromegaly. J Clin Endocrinol Metab. 2017;102(11):4218‐4225. - PMC - PubMed

Publication types

MeSH terms